Working… Menu

A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1 (ILLUMINATE-B)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03905694
Recruitment Status : Active, not recruiting
First Posted : April 5, 2019
Last Update Posted : March 11, 2021
Information provided by (Responsible Party):
Alnylam Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : June 29, 2020
Estimated Study Completion Date : August 19, 2024